According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Shuanghe, a subsidiary of the group, obtained total operating income of 5.615 billion yuan for the six months ended June 30, 2026, a decrease of 3.44%; net profit attributable to shareholders of listed companies was 946 million yuan, a decrease of 3.43% year on year; and basic profit per share was 0.9163 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.